C
Citius Pharmaceuticals, Inc. (CTXR)
NCM – Real Time Price. Currency in USD
0.54
-0.01 (-0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
0.55
+0.01 (1.85%)
After-hours: Jun 26, 2026, 6:18 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.54
-0.01 (-0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
0.55
+0.01 (1.85%)
After-hours: Jun 26, 2026, 6:18 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $4.6M significantly exceed its total debt $808.2K, ensuring strong financial flexibility
Total current liabilities $55.0M surpass Total current assets $31.7M, signaling liquidity issues
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-974.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.58 | 6.05 | 4.0 | |
| Quick ratio | 0.16 | 5.63 | 2.0 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | -974.68 | -16.91 | 1.0 | |
| Weighted average score | 5.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 6M |
| Gross Profit | -180K | -194K | -210K | -214K | 2M |
| Operating Income | -33M | -37M | -42M | -39M | -58M |
| Net Income | -34M | -33M | -39M | -37M | -46M |
| EBITDA | -33M | -37M | -42M | -38M | -56M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 55 | 5.5 |
| Next quarter | 147.72 | -2400 | 5.5 |
| Current year | 428.4 | 44.67 | 10 |
| Next year | 152.31 | 56.68 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -57.72 | -158.25 | -149.99 | 90.01 | 3.3 |
| Y/Y | 999 | -94.48 | 25.2 | 71.36 | 7.8 |
| 3y average | 999 | -4.2 | 13.06 | 2.12 | 5.5 |
| 5y average | 999 | -17.97 | 17.73 | -10.75 | 5.3 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |